
Pfizer Inc Profile last edited on: 4/1/2022
Discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide Year Founded
1949Last Involved Year
2021Key People / Management
Albert Bourla -- CEO
Ian C Read -- Chief Exec. Officer, Pres, Director, Chairman of Exec. Committee, Member of Exec. Compliance Committ
Michael Kirk Ahlijanian --
Laman Alani --
Abdullah R Ali -- Technical Advisor
Heather Nicole Amar -- Strategic Alliances Princ
Naili An --
Elizabeth L Bachert --
Robert Bagdorf --
Jamsheed P Banaji --
Abhijit Banerjee -- Principal II
Ann C Barry -- Director, Licensing & Dev
Akintunde (Tunde) Bello --
Dan Bogaty --
Ian Brookes -- Director, Strategic Plann
Bill Burkth --
Michael T Clark --
Arthur J Cohn --
Barbara Dalton -- Pfizer's Venture Investments
Christine de los Reyes -- Director, Licensing & Dev
Kelleesa A Ewing -- Senior Manager, New Ventu
Jasmine V Ferrer -- Associate Director Licens
Michael L Flakus --
Meredith L Fountain --
Ping Gao --
Maren Grazzini --
Cynthia D Green --
Scott Grenz -- Director of Media
Richard J Griffiths --
Michael J Hageman --
Clive A Hammant -- Director, Licensing & Dev
Stefanie A Hansen --
Stefanie A Hansen --
Michelle L Haven --
James S Hilboldt --
James S Hilboldt Jr --
Roger J Hill --
Jill A Horowitz --
Seth Jacobs --
Paul Jeffrey --
Paul Jeffrey --
John H Johnson -- Director
Elaine Jones -- Executive Director - Venture Capital
Michael J Kennedy --
Robert Knowles --
Karen M Koronkiewicz --
Richard W Korsmeyer --
Erik Kuja --
Brenda K Lammers -- Senior Contract Manager
Lynda S Lee --
Keith S Lerner -- Senior Director, Business
Lorraine B Ling --
Craig Lipset --
Craig H Lipset --
Hui Liu --
Kelly P Longo --
Kelly P Longo --
Jeffrey J Machak -- Analyst
Don A Madren -- Associate Director, Busin
Guilherme Maradei -- Vice President, Enterpris
Philip McGurk -- Manager, Strategic Allian
Jim I McLoughlin --
Deborah A McRonald --
David H Messner -- Business Development and
Jo Kelley Mohr -- Director, Business Develo
Madeline Monaco -- Director, Tech Search
William F Mulholland --
Phillip R Nixon -- Director, Pharmaceutical
Julie A Olson -- Vice President
Herbert S Ormsbee -- Senior Director
Edward D Pagani -- Senior Director & Site He
Tony Parsons --
Kristin Peck -- Executive Vice President, Worldwide Business Development and Innovation
Rebecca Poston --
Richard I Raibman -- Director, Program Plannin
Jan M Reid -- Associate Director, Busin
Stephen S Resnick -- Director of Finance, Worl
Lisa Ricciardi -- Vice President, Licensing
Diana L Sabloff -- Associate Director
Francine R Salamone -- Director
Gavin B Samuels -- Director/Team Leader
John Scaife -- Director
Uwe Schoenbeck --
Catherine A Segal -- Vice President
David Shedlarz -- Chief Financial Officer
Lauren Silverman -- Director, Licensing and D
Robin Sitver -- Senior Director, Strategi
Jeff S Southerton -- Senior Director, Strategi
Celine Stahl-Bayliss -- Director, Licensing & Dev
Elizabeth (Beth) T Stark -- Director, Pfizer Strategi
William D Taylor --
Tania Tretiak -- Legal Counsel
Gwendolyn Turner --
Francis R Victor -- Director, Licensing and B
Christina C Wan -- Associate Director, Strat
John W Watson --
John W Watson -- Senior Director
Gary Whalens -- GCTL Pristiq / Neuroscience at Pfizer
Michael D Wider -- Principal IV
Paul Williamson --
Laura L Winka --
Laura L Winka -- Licensing Coordinator
Hong Xu -- Director, PGRD Licensing
Shiyin Yee -- Senior Manager
Steve T Zelson --
Ian C Read -- Chief Exec. Officer, Pres, Director, Chairman of Exec. Committee, Member of Exec. Compliance Committ
Michael Kirk Ahlijanian --
Laman Alani --
Abdullah R Ali -- Technical Advisor
Heather Nicole Amar -- Strategic Alliances Princ
Naili An --
Elizabeth L Bachert --
Robert Bagdorf --
Jamsheed P Banaji --
Abhijit Banerjee -- Principal II
Ann C Barry -- Director, Licensing & Dev
Akintunde (Tunde) Bello --
Dan Bogaty --
Ian Brookes -- Director, Strategic Plann
Bill Burkth --
Michael T Clark --
Arthur J Cohn --
Barbara Dalton -- Pfizer's Venture Investments
Christine de los Reyes -- Director, Licensing & Dev
Kelleesa A Ewing -- Senior Manager, New Ventu
Jasmine V Ferrer -- Associate Director Licens
Michael L Flakus --
Meredith L Fountain --
Ping Gao --
Maren Grazzini --
Cynthia D Green --
Scott Grenz -- Director of Media
Richard J Griffiths --
Michael J Hageman --
Clive A Hammant -- Director, Licensing & Dev
Stefanie A Hansen --
Stefanie A Hansen --
Michelle L Haven --
James S Hilboldt --
James S Hilboldt Jr --
Roger J Hill --
Jill A Horowitz --
Seth Jacobs --
Paul Jeffrey --
Paul Jeffrey --
John H Johnson -- Director
Elaine Jones -- Executive Director - Venture Capital
Michael J Kennedy --
Robert Knowles --
Karen M Koronkiewicz --
Richard W Korsmeyer --
Erik Kuja --
Brenda K Lammers -- Senior Contract Manager
Lynda S Lee --
Keith S Lerner -- Senior Director, Business
Lorraine B Ling --
Craig Lipset --
Craig H Lipset --
Hui Liu --
Kelly P Longo --
Kelly P Longo --
Jeffrey J Machak -- Analyst
Don A Madren -- Associate Director, Busin
Guilherme Maradei -- Vice President, Enterpris
Philip McGurk -- Manager, Strategic Allian
Jim I McLoughlin --
Deborah A McRonald --
David H Messner -- Business Development and
Jo Kelley Mohr -- Director, Business Develo
Madeline Monaco -- Director, Tech Search
William F Mulholland --
Phillip R Nixon -- Director, Pharmaceutical
Julie A Olson -- Vice President
Herbert S Ormsbee -- Senior Director
Edward D Pagani -- Senior Director & Site He
Tony Parsons --
Kristin Peck -- Executive Vice President, Worldwide Business Development and Innovation
Rebecca Poston --
Richard I Raibman -- Director, Program Plannin
Jan M Reid -- Associate Director, Busin
Stephen S Resnick -- Director of Finance, Worl
Lisa Ricciardi -- Vice President, Licensing
Diana L Sabloff -- Associate Director
Francine R Salamone -- Director
Gavin B Samuels -- Director/Team Leader
John Scaife -- Director
Uwe Schoenbeck --
Catherine A Segal -- Vice President
David Shedlarz -- Chief Financial Officer
Lauren Silverman -- Director, Licensing and D
Robin Sitver -- Senior Director, Strategi
Jeff S Southerton -- Senior Director, Strategi
Celine Stahl-Bayliss -- Director, Licensing & Dev
Elizabeth (Beth) T Stark -- Director, Pfizer Strategi
William D Taylor --
Tania Tretiak -- Legal Counsel
Gwendolyn Turner --
Francis R Victor -- Director, Licensing and B
Christina C Wan -- Associate Director, Strat
John W Watson --
John W Watson -- Senior Director
Gary Whalens -- GCTL Pristiq / Neuroscience at Pfizer
Michael D Wider -- Principal IV
Paul Williamson --
Laura L Winka --
Laura L Winka -- Licensing Coordinator
Hong Xu -- Director, PGRD Licensing
Shiyin Yee -- Senior Manager
Steve T Zelson --
Location Information
235 East 42nd Street
New York, NY 10017-5755
New York, NY 10017-5755
(212) 733-2323 |
www.pfizer.com |
Public Profile
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Extent of SBIR involvement
Synopsis: Techseeker Business Condition
Headquartered
USAEmployment
79,000Revenue
$81.3BPublic/Private
Publicly TradedStock Info
NYSE : PFEReceived SBIR $$
NoTechseeker firm in the news
Date | Title |
---|---|
Jun
25
2008
|
Melior Signs Option Agreement with Pfizer |
Apr
09
2007
|
Melior Enters Research Collaboration With Pfizer |